Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy
Clinical trial NCT06948396 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06948396
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-05-30
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.